Related Experiment Videos
Molecular cloning, expression, and function of osteoclastic calcineurin Aalpha
Li Sun1, Baljit S Moonga, Min Lu
1Mount Sinai Bone Program and Division of Endocrinology, Mount Sinai School of Medicine, New York, 10029, USA. li.sun@mssm.edu
American Journal of Physiology. Renal Physiology
|November 7, 2002
Summary
Researchers developed a novel method to deliver calcineurin Aalpha into osteoclasts, effectively inhibiting bone resorption. This TAT-based approach shows promise for controlling bone loss by targeting osteoclast activity.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Physiology
Background:
- Calcineurin A is a calcium- and calmodulin-dependent phosphatase crucial in cellular signaling.
- Osteoclasts are specialized cells responsible for bone resorption.
- Understanding calcineurin A's role in osteoclasts is key to addressing bone resorption disorders.
Purpose of the Study:
- To investigate the role of calcineurin A in osteoclast-mediated bone resorption.
- To develop a method for delivering functional calcineurin A into osteoclasts.
- To assess the impact of delivered calcineurin A on bone resorption activity.
Main Methods:
- Cloning of rabbit calcineurin Aalpha and Abeta cDNA.
- In situ RT-PCR to analyze calcineurin Aalpha mRNA expression in osteoclasts.
- Construction and transduction of a TAT-calcineurin Aalpha fusion protein into rat osteoclasts.
- Pit assays to measure bone resorption by TAT-calcineurin Aalpha-treated osteoclasts.
Main Results:
- High expression of calcineurin Aalpha mRNA in osteoclasts confirmed.
- TAT-calcineurin Aalpha fusion protein rapidly transduced into over 90% of osteoclasts.
- Transduced TAT-calcineurin Aalpha significantly inhibited bone resorption in a concentration-dependent manner.
- No cytotoxicity or changes in osteoclast number were observed with TAT-calcineurin Aalpha treatment.
Conclusions:
- The TAT-based approach enables effective delivery of calcineurin Aalpha into osteoclasts.
- Delivered calcineurin Aalpha retains its phosphatase activity and inhibits osteoclast bone resorption.
- This strategy offers a potential therapeutic avenue for managing excessive bone resorption.